• Policy
• Vemlidy IMDs compete with lower price
• by Lee, Tak-Sun May 31, 2023 05:37am

• Policy
• Lowest price of dapagliflozin set at 30% of original price
• by Lee, Tak-Sun May 30, 2023 05:33am

• Policy
• "Nurturing biopharmaceuticals as the second semiconductor"
• by Kang, Shin-Kook May 25, 2023 11:05pm

• Policy
• Welireg·Camzyos are approved in Korea
• by Lee, Hye-Kyung May 25, 2023 05:46am

• Policy
• Domestic medical device market share ↑50%
• by Lee, Hye-Kyung May 24, 2023 08:26pm

• Policy
• Domestic DM combi drugs selected for market competitiveness
• by Lee, Tak-Sun May 23, 2023 05:50am

• Policy
• Myelofibrosis tx BMS Inrebic to be covered from June
• by Lee, Tak-Sun May 22, 2023 05:42am

• Policy
• Vemlidy’s price 4.7% ↓...Vemliver’s voluntarily 12.6% ↓
• by Kim, Jung-Ju May 22, 2023 05:42am

• Policy
• Revival of omega-3 fatty acids...4g high-dose recommended
• by Choi, sun May 18, 2023 05:45am

• Policy
• Initial appvl rate of drugs subject to prior review varies
• by Lee, Tak-Sun May 18, 2023 05:45am